GCTK
GlucoTrack, Inc.NASDAQHealthcare$0.86+7.50%ClosedMarket Cap: $488,012
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.26
P/S
0.00
EV/EBITDA
0.43
DCF Value
$6.79
FCF Yield
-3255.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-393.3%
ROA
-247.4%
ROIC
-520.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-3.5M | $-3.6M | $-7.56 | — |
| FY 2025 | $0.00 | NaN% | $-16.1M | $-19.4M | $-21.56 | — |
| Q3 2025 | $0.00 | -Infinity% | $-4.3M | $-4.2M | $4.64 | — |
| Q2 2025 | $0.00 | -Infinity% | $-4.8M | $-4.8M | $-9.62 | — |
| Q1 2025 | $0.00 | -Infinity% | $-3.5M | $-6.8M | $-40.20 | — |
| Q4 2024 | $0.00 | -Infinity% | $-3.9M | $-10.1M | $-21.75 | — |
| FY 2024 | $0.00 | -Infinity% | $-14.5M | $-22.6M | $60.76 | — |
| Q3 2024 | $0.00 | -Infinity% | $-3.3M | $-5.1M | $-18.18 | — |
| Q2 2024 | $0.00 | -Infinity% | $-4.5M | $-4.5M | $-16.40 | — |
| Q1 2024 | $0.00 | -Infinity% | $-3.0M | $-2.9M | $-11.73 | — |
| Q4 2023 | $0.00 | NaN% | $-11.8M | $-2.4M | $-9.05 | — |
| FY 2023 | $0.00 | -Infinity% | $-7.1M | $-7.1M | $-38.30 | — |